global-biopharmaceuticals-market-industry
Published

JUL 2018

Biopharmaceuticals Market - Segmented by Type of Products and Applications - Growth, Trends and Forecasts (2018 - 2023)

Purchase Report
$4250
Single user license
$4500
Team license
$8750
Corporate license

The global biopharmaceuticals market is estimated to reach USD 341.16 billion in 2023. The market is expected to register a CAGR of 8.5% during the forecast period (2018 – 2023). North America dominates the market due to rapid technological advancements.

Increasing Acceptance for Biopharmaceuticals and Significant Market Demand

Opportunities in biopharmaceuticals have been increasing over the past decade. The efficacy and the safety of the drugs are some of the key product features that drive the market’s growth. There have been biopharmaceutical products that are improving the quality of life and reducing the death rates in patients with HIV/AIDs, cancer, cystic fibrosis, rheumatoid arthritis. Biopharmaceuticals have reduced the number of deaths caused due to cancer and HIV/AIDS in the last decade. The efficacy of the drugs and their safety has increased the acceptance for biopharmaceuticals.

High-end Manufacturing Requirements

Unlike conventional pharmaceuticals, biopharmaceuticals are manufactured using living biological systems. Due to this, biopharmaceutical manufacturing requires specialized equipment and devices such as incubators that can support these biological systems. The cost of these devices and equipment is high as compared to regular manufacturing equipment. Along with this, most biopharmaceuticals require custom built manufacturing equipment and highly specialized personnel to operate them. Due to these high-end manufacturing requirements, the resources and time required to setup a biopharmaceutical manufacturing facility is very high, which makes scaling really tough. So, these factors are acting as a restraint for the BIOPHARMACEUTICALS market.

North America to Dominate the Market

The biopharmaceuticals market is segmented by type of treatment and geography. By geography, it is segmented into North America, Europe, Asia-Pacific, the Middle East and Africa and South America.

North America dominates the biopharmaceuticals market due to rapid technological advancements and high investment & funding to support development of biopharmaceuticals. Asia-Pacific is also expected to propel the biopharmaceuticals market owing to factors, such as increasing accessibility to healthcare facilities in the region and increasing economic growth.

Key Developments In The Market

  • January 2018: GE Healthcare’s Flex Factory single-use bio manufacturing platform has been selected by Clover Biopharmaceuticals, a Chinese developer of biologics, for its new facility located in Changxing, Zhejiang.
  • January 2018: Sandoz, a Novartis division and the global leader in biosimilars, announced a global partnership with Asia's premier biopharmaceuticals company, Biocon, to develop, manufacture and commercialize multiple biosimilars in immunology and oncology for patients worldwide.

Major key players: AbbVie, Amgen, Bristol – Myers Squibb, Eli Lily & Co., Johnson & Johnson, Merck & Co. Inc, GlaxoSmithKline PLC, Roche, Pfizer and Novartis AG, among others.

Reasons To Purchase This Report

  • Market analysis for the global biopharmaceuticals market, with region-specific assessments and competition analysis on a global and regional scale
  • Analyzing various perspectives of the company with the help of Porter’s five forces analysis
  • The treatment type that is expected to dominate the market
  • Regions that are expected to witness fastest growth during the forecast period
  • Identify the latest developments, market shares and strategies employed by the major market players.
  • 3 months analyst support along with the Market Estimate sheet in excel

Customization Of The Report

  • This report can be customized to meet your requirements. Please connect with our analyst, who will ensure you get a report that suits your needs.
Purchase Report
$4250
Single user license
$4500
Team license
$8750
Corporate license
Our Clients Include View All

Looking to Customize Report?